ACTIVE SUBSTANCE / INN

CYCLOSPORINE

Brand name(s): CYCLOSPORINE, RESTASIS, SANDIMMUNE, VEVYE, GENGRAF, CEQUA, RESTASIS MULTIDOSE, NEORAL
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA065167
NDA050716
ACTIVE SUBSTANCE
Cyclosporine
REGULATORS
FDA
SPONSORS / MAH
ABBVIE, PHARM ASSOC, NOVARTIS
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SANDIMMUNENDA050625NOVARTISPrescription
NEORALNDA050716NOVARTISPrescription
CYCLOSPORINEANDA065040APOTEXPrescription
CYCLOSPORINEANDA065167PHARM ASSOCDiscontinued
RESTASIS MULTIDOSENDA050790ABBVIEPrescription
RESTASISNDA050790ABBVIEPrescription
NEORALNDA050715NOVARTISDiscontinued
VEVYENDA217469HARROW EYEPrescription
CEQUANDA210913SUN PHARMPrescription
GENGRAFANDA065003ABBVIEPrescription

FULL INTELLIGENCE ON CYCLOSPORINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →